Protos is a unique and inimitable dual mechanism. Will increase both the likelihood of bone formation and reduce bone resorption. First, it acts as an agonist of the calcium-sensing receptor on signaling. There is also a new bone, stimulating bone formation process.
In addition, there is a new study suggests that the increase of osteoprotegerin with the use of Protos shows. This is the protein that helps boneseach type of bone loss. It can also help reduce the likelihood of bone resorption. This new and innovative mechanism of action, coupled processes of bone Protos distances to turn.
Home First Aid
We need to extend our gratitude to this innovation. It will act as a key in the treatment of postmenopausal osteoporosis. It 'a crucial role in portraying the bones of our body system. E 'due to the fact that significantly reduce the risk of hip fracture. Will adornhip fracture efficacy of anti-thy bones. It will also keep you from the risk of fractures. This, in turn, the effectiveness of your vertebrae.
This medication is known as strontium ranelate. This is extremely exciting addition to the drugs we have for the treatment of osteoporosis. The efficacy of strontium ranelate against breakage that has been proven in randomized controlled trials has been of great help. We know from studies that have beenheld that this drug reduces the risk of vertebral fractures. It also reduces the risk of devastating consequences of osteoporosis, which is a hip fracture.
It seems that in postmenopausal women with vertebral fractures, which have very low bone density are at high risk of hip fractures. Since they are a big risk in relation to their bone status, the drug could actually help them to overcome this situation.
Protos - An aid for postmenopausal osteoporosis
No comments:
Post a Comment